Skip to main content
. 2020 Nov 10;6(4):00265-2020. doi: 10.1183/23120541.00265-2020

TABLE 4.

Longitudinal changes in clinical outcomes in chronic rhinosinusitis (CRS) patients when stratified according to the presence or absence of sensitisation to moulds/Staphylococcus aureus enterotoxins (SEs) (≥0.10 UA/mL)

Moulds/SEs+ (n=15) Moulds/SEs (n=33) p-value
Before 12 months after p-value# Before 12 months after p-value#
Systemic biomarkers
 Blood eosinophil count per µL 449 (262, 653) 341 (203, 487) 0.08 178 (85, 310) 177 (80, 317) 0.42 0.10
 Serum periostin ng·mL−1 112 (93, 159) 102 (64, 125) 0.36 80 (72, 100) 86 (69, 111) 0.80 0.16
 Sensitisation to moulds 11 (73) 10 (67) 0 (0) 0 (0)
 Sensitisation to SEs 11 (73) 7 (47) 0 (0) 6 (18)
Upper airway markers
 Nasal polyps recurrence, presence, n (%)+ 4 (27) 3 (9) 0.18
 Lund–Mackay scores 14 (10, 15) 9 (6,13) 0.004 11 (7, 16) 5 (2, 11) <0.0001 0.81
 SNOT-22 scores 31 (22, 51) 24 (5, 32) 0.03 20 (12, 33) 10 (5, 20) 0.0003 0.80
 Open Essence scores 4 (0, 8) 6 (0, 9) 0.06 5 (0, 8) 6 (4, 8) 0.08 0.67
Lower airway markers
 New asthma onset, presence§ 1 (25) 6 (24) >0.99
 AQLQ pointsƒ 5.9 (4.9, 6.7) 6.4 (6.0, 6.7) 0.02 5.6 (5.5, 6.57) 6.2 (6.1, 7) 0.03 0.82
 Sputum eosinophils %## 3.3 (0.9, 27.2) 3.4 (0.5, 12.1) 0.76 0 (0, 2.0) 1.0 (0, 4.5) 0.09 0.33
 Sputum periostin ng·mL−1## 27.2 (14, 47.8) 8.1 (1.7, 20.8) 0.02 9.8 (2.3, 15.6) 3.3 (1.8, 9.0) 0.004 0.24
FeNO ppb¶¶ 50.4 (33.6, 73.8) 32.7 (24.6, 54.6) 0.56 26.4 (17.6, 38.0) 26.3 (15.4, 46.0) 0.86 0.34

Data are presented as median (25th percentile, 75th percentile) or n (%), unless otherwise stated. Moulds: Alternaria and Aspergillus; SEs: Staphylococcus enterotoxins A and B; SNOT-22: Sinonasal Outcome Test-22; AQLQ: Asthma Quality of Life Questionnaire; FeNO: fractional nitric oxide. #: Analysed by Wilcoxon single rank test; : Analysed by Wilcoxon rank-sum test or Fischer's exact test; +: n=34 (moulds/SEs+/–: 12/22; §: n=30 (moulds/SEs+/–: 5/25); ƒ: n=18 (moulds/SEs +/–: 10/8; ##: n=39 (moulds/SEs +/–: 13/26); ¶¶: n=47 (moulds/SEs +/–: 14/33).